Matthew Richard Moore, SVP and Chief Business Officer at Arcutis Biotherapeutics, Inc. (ARQT), sold 3,468 shares at $11.12 ($39K) on 2024-03-04, disclosed to the SEC on 2024-03-06.
Scheduled sale ($39k) by SVP and Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| Filing → |